U.S. House · 118th Congress · H.R. 4053
Studying Suboxone Act
To provide for the review of the scheduling under the Controlled Substances Act of buprenorphine-naloxone combination products, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Ann M. KusterD-NH-2
- Introduced
- June 13, 2023, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (3)
2 Republicans, 1 Democrat. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Earl L. "Buddy" CarterR-GA-1
Signed on later
- Paul TonkoD-NY-20June 20, 2023
- Marcus J. MolinaroR-NY-19January 3, 2024